Abstract:OBJECTIVE:Previous studies have shown that adipose-derived serum retinol-binding protein 4 (RBP4) levels are increased in insulin-resistant mouse models and in subjects with insulin resistance or type 2 diabetes. However, the association of visceral fat and serum RBP4 has not been studied. The purpose of this study was to investigate the relationship between serum RBP4 and regional fat distribution in Chinese subjects with and without type 2 diabetes.DESIGN:We measured serum RBP4 concentrations from 1033 Chinese subjects with various degrees of obesity and tested the association between visceral adiposity and serum RBP4. In a subgroup of this study, euglycemic-hyperinsulinemic clamp was performed to measure insulin sensitivity. The association between visceral adiposity and serum RBP4 was also determined in response to rosiglitazone treatment in a subgroup of patients with diabetes.RESULTS:Serum RBP4 level was positively correlated with visceral adipose area in male (r = 0.171; P < 0.001) and female (r = 0.215; P < 0.001) subjects. However, there was no correlation between serum RBP4 and body mass index. Subjects with visceral obesity had higher serum RBP4 concentrations than those without visceral obesity in both men and women. Rosiglitazone treatment in patients with diabetes resulted in a lower serum RBP4 level (35.2 +/- 10.2 vs. 24.9 +/- 5.6 microg/ml, before vs. after treatment). These changes were accompanied by improved insulin sensitivity and reductions in visceral fat area. The latter was found to be highly correlated with the decline of serum RBP4 levels (r = 0.471; P = 0.027).CONCLUSIONS:Serum RBP4 level is positively associated with visceral adiposity in both men and women. Our data suggest that RBP4 may contribute to the development of insulin resistance along with other adipokines.

Expression and Regulation of Retinol Binding Protein 4 Mrna in Human Adipose Tissue in Obese and Type 2 Diabetics

Significance of RBP4 in Patients with Gestational Diabetes Mellitus: a Case-Control Study of Han Chinese Women

Increased Retinol-Free RBP4 Contributes to Insulin Resistance in Gestational Diabetes Mellitus

Retinol-binding Protein-4 and Nonalcoholic Fatty Liver Disease

Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and Without Type 2 Diabetes

Change of Retinol Binding Protein-4 Concentrations in Patients with Type 2 Diabetes Mellitus and Its Relationship with Glucose and Lipid Metabolism

Effect of RBP4 Gene Variants on Circulating RBP4 Concentration and Type 2 Diabetes in a Chinese Population

Change and Clinical Significance of Serum Retinal Binding Protein-4 Levels in Patients with Obesity and Type 2 Diabetes 1

Serum levels of retinol binding protein 4, adiponectin and tumor necrosis factor-alpha and their correlations in patients with obesity and type 2 diabetes mellitus

Suppression of Retinol-Binding Protein 4 with RNA Oligonucleotide Prevents High-Fat Diet-Induced Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease in Mice

High Fat or High Carbohydrate Diet Induces an Increase in Retinol-Binding Protein 4 Expression in Epididymal Fat Tissue of Rats

Serum Retinol Binding Protein 4 and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

The Relationship Between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

Effects of Variation in Retinol Binding Protein 4 Gene and Adipose Specific Expression of Gestational Diabetes in Beijing, China.

1718-P: Retinol-Binding Protein 4, an Adipokine Provoking Pancreatic Beta-Cell Apoptosis in Type 2 Diabetes

Circulating Retinol Binding Protein 4 is Inversely Associated with Pancreatic Β Cell Function Across the Spectrum of Glycemia

Relationship between type 2 diabetes and retinol binding protein 4 and its genetic polymorphism

Retinol binding protein 4 and type 2 diabetes: from insulin resistance to pancreatic β-cell function

Elevated RBP4 Plasma Levels Were Associated with Diabetic Retinopathy in Type 2 Diabetes.

Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia.

Retinol binding protein 4 and polycystic ovary syndrome and gestational diabetes mellitus